Tag: Eversense
Senseonics Gets FDA Approval for Eversense Implantable CGM System
Senseonics, a company that develops implantable continuous glucose monitoring (CGM) system for people with diabetes, received FDA approval for the non-adjunctive indication (dosing claim)...
Senseonics & Glooko Partner Up for Integrated Diabetes Management
Senseonics, the maker of Eversense, the world’s first long-term CGM system, announced the integration of Eversense CGM data into the Glooko diabetes data management...
Senseonics’ Eversense Now Receiving Coverage from Aetna
Senseonics, a Germantown, Maryland-based medtech startup developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Aetna, the third largest...